Mitocell is the carrier of mitochondria, supplying mitochondria to damaged and aging cells, using the transport of mitochondria to produce therapeutic effects, mainly using unique patented culture methods and reagents to induce and cultivate ordinary fat stem cells into Mitocell, which has better anti-stress Ability, excellent mitochondrial function, stem cell activity increased by at least 120%. Its mechanism of action is that MitoCell can change the microenvironment in the brain, such as secreting neurotrophic factor BDNF to reduce inflammation, and promoting autophagy to remove toxic α-synuclein protein, protect and repair damaged dopamine neurons (DA neurons), and Promote DA regeneration. Potency experiments have confirmed that BDNF is one of the main potency markers of MitoCell, and the therapeutic effect of MitoCell has been confirmed by animal experiments to be better than ordinary fat stem cells. It can be used in the treatment of Parkinson's disease, dementia, nerve repair, myocardial infarction, lung injury, diabetes, liver cirrhosis, degenerative arthritis, kidney failure, tendon injury, autoimmune disease and other diseases

1.Mitocell has passed the review of TFDA, and the cell preparation can be used for the phase I clinical trial of Parkinson's disease through intracranial injection.
2.Establish QA/QC indicators for stem cell with mitochondrial analysis technology to ensure MitoCell quality standards.
3.The mechanism of action is clear, it can change the microenvironment in the brain, and promote the regeneration and repair of dopamine neurons in the substantia nigra.
4.The product has a wide range of applications and has immune regulation function. In the future, it can be applied to the supportive therapy of new coronary pneumonia, reduce the immune storm caused by ARDS, and reduce the pulmonary fibrosis after recovery.